TAMIFLU 6 mg/ml, powder for oral suspension bottle
Active ingredients: Oseltamivir, Oseltamivir phosphate
Commercialized according to BDPMDispensing in France: Prescription only
Powder for oral suspensionbottleorale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- TAMIFLU 6 mg/ml, poudre pour suspension buvable
- Pharmaceutical form
- poudre pour suspension buvable
- Route of administration
- orale
- Presentation description
- 1 flacon(s) en verre brun avec fermeture de sécurité enfant avec adaptateur avec seringue(s) pour administration orale avec gobelet(s) doseur(s)
- Marketing authorisation holder
- ROCHE REGISTRATION (ALLEMAGNE)
- Reimbursement according to BDPM
- 15 %
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 26 Nov 2012
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
64086275CIP72206906CIP133400922069067Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| OSÉLTAMIVIR (PHOSPHATE D')poudre | 39,4 mg · 1 g de poudre pour suspension buvable | SA |
| OSÉLTAMIVIRpoudre | 30 mg · 1 g de poudre pour suspension buvable | FT |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.